Comparative effectiveness of natalizumab ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
Background: For treatment of relapsing-remitting multiple sclerosis (RRMS), a broad range of disease-modifying therapies (DMT) is available. However, few comparative effectiveness studies between different drugs have been performed. Objectives: This study aimed to compare the efficacy and treatment...
Uloženo v:
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2022-12-01
|
| Edice: | Therapeutic Advances in Neurological Disorders |
| On-line přístup: | https://doi.org/10.1177/17562864221142924 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|